Insider Transactions in Q1 2026 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2026
|
Eric Venker President & Immunovant CEO |
SELL
Open market or private sale
|
Direct |
200,000
-10.78%
|
$4,200,000
$21.92 P/Share
|
|
Jan 12
2026
|
Eric Venker President & Immunovant CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+9.73%
|
$600,000
$3.85 P/Share
|